CEVA Valuation
Is CEVA * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CEVA * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CEVA * (MX$362) is trading above our estimate of fair value (MX$254.89)
Significantly Below Fair Value: CEVA * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CEVA *?
Other financial metrics that can be useful for relative valuation.
What is CEVA *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$451.83m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.2x |
Enterprise Value/EBITDA | -28.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CEVA *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7.4x | ||
688049 Actions Technology | 6x | 26.6% | CN¥3.3b |
688458 Maxic Technology | 6.9x | 27.3% | CN¥3.4b |
688620 Guangzhou Anyka Microelectronics | 5.9x | 16.6% | CN¥3.4b |
600770 Jiangsu ZongyiLTD | 10.9x | n/a | CN¥3.2b |
CEVA * CEVA | 4.8x | 10.7% | Mex$451.8m |
Price-To-Sales vs Peers: CEVA * is good value based on its Price-To-Sales Ratio (4.8x) compared to the peer average (7.4x).
Price to Earnings Ratio vs Industry
How does CEVA *'s PE Ratio compare vs other companies in the Global Semiconductor Industry?
Price-To-Sales vs Industry: CEVA * is expensive based on its Price-To-Sales Ratio (4.8x) compared to the Global Semiconductor industry average (3.6x).
Price to Sales Ratio vs Fair Ratio
What is CEVA *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 4.8x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CEVA *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$362.00 | Mex$475.22 +31.3% | 14.9% | Mex$554.42 | Mex$357.69 | n/a | 7 |
Jun ’25 | n/a | Mex$445.98 0% | 14.9% | Mex$520.31 | Mex$335.69 | n/a | 7 |
May ’25 | n/a | Mex$474.87 0% | 7.3% | Mex$528.44 | Mex$426.16 | n/a | 7 |
Apr ’25 | n/a | Mex$474.87 0% | 7.3% | Mex$528.44 | Mex$426.16 | n/a | 7 |
Mar ’25 | n/a | Mex$474.87 0% | 7.3% | Mex$528.44 | Mex$426.16 | n/a | 7 |
Feb ’25 | n/a | Mex$439.17 0% | 9.4% | Mex$500.45 | Mex$357.47 | n/a | 7 |
Jan ’25 | n/a | Mex$439.17 0% | 9.4% | Mex$500.45 | Mex$357.47 | n/a | 7 |
Dec ’24 | n/a | Mex$439.17 0% | 9.4% | Mex$500.45 | Mex$357.47 | n/a | 7 |
Nov ’24 | n/a | Mex$481.65 0% | 17.3% | Mex$631.04 | Mex$360.60 | n/a | 7 |
Oct ’24 | n/a | Mex$478.72 0% | 26.9% | Mex$765.46 | Mex$340.20 | n/a | 7 |
Sep ’24 | n/a | Mex$478.72 0% | 26.9% | Mex$765.46 | Mex$340.20 | n/a | 7 |
Aug ’24 | n/a | Mex$577.85 0% | 18.9% | Mex$791.40 | Mex$404.49 | n/a | 7 |
Jul ’24 | n/a | Mex$577.85 0% | 18.9% | Mex$791.40 | Mex$404.49 | n/a | 7 |
Jun ’24 | n/a | Mex$577.85 0% | 18.9% | Mex$791.40 | Mex$404.49 | n/a | 7 |
May ’24 | n/a | Mex$722.72 0% | 10.1% | Mex$833.91 | Mex$593.00 | n/a | 7 |
Apr ’24 | n/a | Mex$722.72 0% | 10.1% | Mex$833.91 | Mex$593.00 | n/a | 7 |
Mar ’24 | n/a | Mex$722.72 0% | 10.1% | Mex$833.91 | Mex$593.00 | n/a | 7 |
Feb ’24 | Mex$618.00 | Mex$690.91 +11.8% | 13.4% | Mex$870.55 | Mex$580.37 | n/a | 7 |
Jan ’24 | n/a | Mex$690.91 0% | 13.4% | Mex$870.55 | Mex$580.37 | n/a | 7 |
Dec ’23 | n/a | Mex$690.91 0% | 13.4% | Mex$870.55 | Mex$580.37 | n/a | 7 |
Nov ’23 | n/a | Mex$944.40 0% | 19.3% | Mex$1,201.96 | Mex$701.14 | n/a | 7 |
Oct ’23 | n/a | Mex$944.40 0% | 19.3% | Mex$1,201.96 | Mex$701.14 | n/a | 7 |
Sep ’23 | n/a | Mex$944.40 0% | 19.3% | Mex$1,201.96 | Mex$701.14 | n/a | 7 |
Aug ’23 | n/a | Mex$1,042.94 0% | 17.9% | Mex$1,251.52 | Mex$771.77 | n/a | 7 |
Jul ’23 | n/a | Mex$1,039.74 0% | 16.3% | Mex$1,219.81 | Mex$752.22 | n/a | 7 |
Jun ’23 | Mex$690.00 | Mex$1,039.74 +50.7% | 16.3% | Mex$1,219.81 | Mex$752.22 | n/a | 7 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.